(3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid

C102H115ClN26O37S — CID 161413590

About (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid

(3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid (PubChem CID 161413590) has the molecular formula C102H115ClN26O37S and a molecular weight of 2364.71 g/mol. Its IUPAC name is (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid.

Molecular Properties

• Compound Name: (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid
• PubChem CID: 161413590
• Molecular Formula: C102H115ClN26O37S
• Molecular Weight: 2364.71 g/mol
• Exact Mass: 2362.73
• IUPAC Name: (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid
• SMILES: COc1ccc(C(=O)NN2CCC(=O)N3CCC[C@@H](C(=O)N[C@H](C=O)CC(=O)O)N3C2=O)cc1.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cc4ccccc4s3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3ccc(O)cc3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cccc(Cl)c3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cccnc3)C(=O)N12
• InChI: InChI=1S/C22H23N5O7S.C21H25N5O8.C20H22ClN5O7.C20H23N5O8.C19H22N6O7/c28-12-14(11-19(30)31)23-20(32)15-5-3-8-26-18(29)7-9-25(22(34)27(15)26)24-21(33)17-10-13-4-1-2-6-16(13)35-17;1-34-15-6-4-13(5-7-15)19(31)23-24-10-8-17(28)25-9-2-3-16(26(25)21(24)33)20(32)22-14(12-27)11-18(29)30;21-13-4-1-3-12(9-13)18(31)23-24-8-6-16(28)25-7-2-5-15(26(25)20(24)33)19(32)22-14(11-27)10-17(29)30;26-11-13(10-17(29)30)21-19(32)15-2-1-8-24-16(28)7-9-23(20(33)25(15)24)22-18(31)12-3-5-14(27)6-4-12;26-11-13(9-16(28)29)21-18(31)14-4-2-7-24-15(27)5-8-23(19(32)25(14)24)22-17(30)12-3-1-6-20-10-12/h1-2,4,6,10,12,14-15H,3,5,7-9,11H2,(H,23,32)(H,24,33)(H,30,31);4-7,12,14,16H,2-3,8-11H2,1H3,(H,22,32)(H,23,31)(H,29,30);1,3-4,9,11,14-15H,2,5-8,10H2,(H,22,32)(H,23,31)(H,29,30);3-6,11,13,15,27H,1-2,7-10H2,(H,21,32)(H,22,31)(H,29,30);1,3,6,10-11,13-14H,2,4-5,7-9H2,(H,21,31)(H,22,30)(H,28,29)/t14-,15-;14-,16-;14-,15-;13-,15-;13-,14-/m00000/s1
• InChIKey: VVUFFMMIDUIYIN-SCLWBAJFSA-N
• XLogP: -1.41
• TPSA: 824.50 Ų
• H-Bond Donors: 16
• H-Bond Acceptors: 34
• Rotatable Bonds: 36
• Heavy Atoms: 167
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2364.71
LogP ≤ 5	-1.41
H-Bond Donors ≤ 5	16
H-Bond Acceptors ≤ 10	34

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?

The IUPAC name of (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid (CID 161413590) is (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid.

What is the SMILES notation for (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?

The canonical SMILES for (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid is COc1ccc(C(=O)NN2CCC(=O)N3CCC[C@@H](C(=O)N[C@H](C=O)CC(=O)O)N3C2=O)cc1.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cc4ccccc4s3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3ccc(O)cc3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cccc(Cl)c3)C(=O)N12.O=C[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN2C(=O)CCN(NC(=O)c3cccnc3)C(=O)N12.

What is the InChIKey of (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?

The InChIKey is VVUFFMMIDUIYIN-SCLWBAJFSA-N. The full InChI is InChI=1S/C22H23N5O7S.C21H25N5O8.C20H22ClN5O7.C20H23N5O8.C19H22N6O7/c28-12-14(11-19(30)31)23-20(32)15-5-3-8-26-18(29)7-9-25(22(34)27(15)26)24-21(33)17-10-13-4-1-2-6-16(13)35-17;1-34-15-6-4-13(5-7-15)19(31)23-24-10-8-17(28)25-9-2-3-16(26(25)21(24)33)20(32)22-14(12-27)11-18(29)30;21-13-4-1-3-12(9-13)18(31)23-24-8-6-16(28)25-7-2-5-15(26(25)20(24)33)19(32)22-14(11-27)10-17(29)30;26-11-13(10-17(29)30)21-19(32)15-2-1-8-24-16(28)7-9-23(20(33)25(15)24)22-18(31)12-3-5-14(27)6-4-12;26-11-13(9-16(28)29)21-18(31)14-4-2-7-24-15(27)5-8-23(19(32)25(14)24)22-17(30)12-3-1-6-20-10-12/h1-2,4,6,10,12,14-15H,3,5,7-9,11H2,(H,23,32)(H,24,33)(H,30,31);4-7,12,14,16H,2-3,8-11H2,1H3,(H,22,32)(H,23,31)(H,29,30);1,3-4,9,11,14-15H,2,5-8,10H2,(H,22,32)(H,23,31)(H,29,30);3-6,11,13,15,27H,1-2,7-10H2,(H,21,32)(H,22,31)(H,29,30);1,3,6,10-11,13-14H,2,4-5,7-9H2,(H,21,31)(H,22,30)(H,28,29)/t14-,15-;14-,16-;14-,15-;13-,15-;13-,14-/m00000/s1.

What are the key properties of (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid?

(3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid has a molecular weight of 2364.71 g/mol, XLogP of -1.41, 36 rotatable bonds, 16 hydrogen bond donors, and 34 hydrogen bond acceptors.

Where does this data come from?

All data for (3S)-3-[[(10S)-2-(1-benzothiophene-2-carbonylamino)-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(3-chlorobenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-1,5-dioxo-2-(pyridine-3-carbonylamino)-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-hydroxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid;(3S)-3-[[(10S)-2-[(4-methoxybenzoyl)amino]-1,5-dioxo-3,4,7,8,9,10-hexahydropyridazino[1,2-a][1,2,4]triazepine-10-carbonyl]amino]-4-oxobutanoic acid is sourced from PubChem (CID 161413590), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).